In This Article:
As the U.S. stock market navigates a landscape marked by cautious optimism following a benign inflation reading, investors are closely monitoring potential volatility amid ongoing economic developments and policy decisions. In this context, growth companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those closest to the business and may offer robust earnings potential despite broader market uncertainties.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Atour Lifestyle Holdings (NasdaqGS:ATAT) | 26% | 25.7% |
| Super Micro Computer (NasdaqGS:SMCI) | 14.4% | 24.3% |
| Duolingo (NasdaqGS:DUOL) | 14.7% | 34.6% |
| On Holding (NYSE:ONON) | 19.1% | 29.4% |
| Clene (NasdaqCM:CLNN) | 21.6% | 59.2% |
| EHang Holdings (NasdaqGM:EH) | 32.8% | 81.5% |
| Credo Technology Group Holding (NasdaqGS:CRDO) | 13.4% | 66.3% |
| BBB Foods (NYSE:TBBB) | 22.9% | 41.5% |
| Credit Acceptance (NasdaqGS:CACC) | 14.0% | 49% |
| ARS Pharmaceuticals (NasdaqGM:SPRY) | 19.7% | 70.7% |
Let's uncover some gems from our specialized screener.
ChromaDex
Simply Wall St Growth Rating: ★★★★☆☆
Overview: ChromaDex Corporation is a bioscience company that develops healthy aging products, with a market cap of $436.34 million.
Operations: The company generates revenue through three main segments: Ingredients ($16.95 million), Consumer Products ($71.72 million), and Analytical Reference Standards and Services ($3.00 million).
Insider Ownership: 30.5%
Earnings Growth Forecast: 81.8% p.a.
ChromaDex has demonstrated significant growth potential, with revenue forecasted to grow at 18.1% annually, surpassing the US market average. Recent developments include a nationwide rollout of Niagen IV, enhancing its product reach and contributing to its projected 15% revenue increase for 2024. The company has shown improved profitability with US$1.88 million in net income for Q3 2024 compared to a loss last year. Insider activity shows more buying than selling recently, indicating confidence in future performance.
-
Get an in-depth perspective on ChromaDex's performance by reading our analyst estimates report here.
-
The valuation report we've compiled suggests that ChromaDex's current price could be quite moderate.
Root
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Root, Inc. operates in the United States offering insurance products and services, with a market cap of approximately $1.08 billion.
Operations: The company generates revenue of $1.04 billion from offering insurance products to customers in the United States.